Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03545139
Other study ID # NeoMTA in Revascularization
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date September 1, 2019
Est. completion date September 2021

Study information

Verified date February 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

- To evaluate and compare the degree of tooth discoloration in tooth crowns induced by Neo MTA versus white MTA over time.

- Evaluation of the effectiveness of Neo MTA as coronal plug in revascularization of immature teeth with necrotic pulp.


Description:

The new formulation of MTA (NeoMTA) does not contain bismuth oxide, will be used in revascularization of nonvital immature permanent anterior teeth.

to evaluate the effectiveness of Neo MTA as coronal plug and compare the degree of tooth discoloration in tooth crowns induced by Neo MTA versus white MTA over time.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 2021
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group 7 Years to 15 Years
Eligibility Inclusion Criteria:

- Age of patients: 7-15years old.

- Free from any systemic diseases that may affect the normal healing process.

- Tooth with immature root apex.

- Traumatically or cariously exposed non vital permanent anterior tooth.

- Pulp space not needed for post and core for final restoration.

- Compliant patient/parent

Exclusion Criteria:

- Patients having allergy to medicaments and antibiotics necessary to complete procedure.

- Tooth with vital pulp or complete root formation.

- Teeth with internal or external root resorption.

- Un-cooperative patients.

- Luxative injuries.

- Teeth with a root fracture

- Alveolar fracture

- Subjects with chronic systemic illness.

- Subjects with poor oral hygiene.

- Compromised remaining tooth structure as teeth with extensive loss of coronal tissue will require restoration with a post that will occupy the space required for blood clot formation.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
NeoMTA nusmile
A new formulation of MTA was developed in which bismuth oxide was omitted.
White MTA
Revascularization with Conventional white mineral trioxide aggregate as coronal plug.

Locations

Country Name City State
Egypt Faculty of Oral & Dental Medicine Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Discoloration/ Staining potential Using spectrophotometer by operator 9 month
Secondary Pain on biting Verbal questioning of the patient 9 month
Secondary Pain on percussion Using back of the mirror 9 month
Secondary Sinus or fistula, recurrent swelling Visual examination by operator 9 month
Secondary Root lengthening Radiographic Digora image analysis software i.e. Digora for windows software DFW 9 month